Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04473482 · ClinicalTrials.gov registry record · NA

Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial

A NA study of Liver Diseases and Alcohol-Related Disorders, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04473482 is a NA study of Liver Diseases and Alcohol-Related Disorders that has completed, run by University of Michigan. The registered enrollment target is 60 participants, below the 61,157-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04473482, a NA study of Liver Diseases and Alcohol-Related Disorders, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their engagement with treatment and reduce alcohol use. This is an important area to study to help create ways to increase participants' knowledge about different treatment options as well as increase likelihood of seeking and participating in alcohol use disorder treatments.

Interventions

  • BEHAVIORAL Michigan Alcohol Improvement Network-Alcohol Reduction and Treatment tool

Study Locations (1)

Michigan

  • The University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-09-23
Est. Completion 2022-06-30
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04473482

The ClinicalTrials.gov registry entry for NCT04473482 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,157-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Michigan Alcohol Improvement Network-Alcohol Reduction and Treatment tool is the first listed.

NCT04473482 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04473482 about?

NCT04473482 is a clinical study titled "Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial". The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their engagement with treatment and reduce alcohol use. This is an important area to study to help create ...

What is the current status of trial NCT04473482?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-09-23. Estimated completion is 2022-06-30.

What conditions does trial NCT04473482 study?

This clinical trial studies the following conditions: Liver Diseases, Alcohol-Related Disorders.

What interventions are being tested in trial NCT04473482?

The interventions under investigation include: Michigan Alcohol Improvement Network-Alcohol Reduction and Treatment tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT04473482?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04473482 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.